Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Researchers Use ‘Big Data’ Approach to Map the Relationships Between Human and Animal Diseases

Published: Thursday, July 17, 2014
Last Updated: Thursday, July 17, 2014
Bookmark and Share
EID2 database used to prevent and tackle disease outbreaks around the globe.

Researchers at the University of Liverpool are building the world's most comprehensive database describing human and animal pathogens, which can be used to prevent and tackle disease outbreaks around the globe.

The Enhanced Infectious Diseases (EID2) database has been developed by the Liverpool University Climate and Infectious Diseases of Animals (LUCINDA) team and is funded by a BBSRC Strategic Tools and Resources Development Fund grant.

Effectively mapping the relationships between human and animal diseases and their hosts, disease-causing pathogens and the ways in which pathogens are transmitted can offer huge benefits when it comes to knowing what the disease risks are in a population or geographical area, and how best to manage and eliminate them.

The EID2 team realized that there was a potential treasure trove of data already available in the scientific literature and in pre-existing databases, which was just waiting to be mined for useful insights - a 'Big Data' approach. 'Big Data' is about utilizing large datasets which may already have been collected, but which may be unstructured, and not fit into a conventional data-frame, by using often high performance and/or complex computing technologies. The emphasis on Big Data has increased recently because people have realized that the data that they have collected routinely, if used cleverly, can contain much more useful and potentially extra information than previously thought.

By using openly accessible information in a new way, data from EID2 has been used in work to trace the history of human and animal diseases, to predict the effects of climate change on pathogens, to produce maps of which diseases are most likely in some areas and to categorize the complex relationships between human and animal carriers and hosts of numerous pathogens.

Epidemiologist Dr Marie McIntyre, one of the EID2 team, said: "The database is matchless in scale, and has the capacity to hold data on all known human and animal pathogens, when detailed information becomes available."

"We use largely automated procedures to collate data on human and animal pathogens: where, when, and in which hosts there is evidence of their occurrence.

"After scientists have sequenced part or all of a pathogen's DNA or RNA, they usually upload the sequence to public databases, and include information (called metadata) on where, when and from which host the pathogen was obtained.

"EID2 is unique in extracting the information on pathogens from this metadata and as there are already tens of millions of sequence uploads to look at, and millions more are added every year, EID2 has the capacity to become a comprehensive, definitive source of pathogen and disease information.

"In addition, the sequence data is supplemented with information from the NCBI's database of scientific publications, PubMed. The procedures used for identifying the hosts in which pathogens occur, and where they occur, are objective, and the information the EID2 contains can be regularly updated and improved as more detailed information becomes available."

All together there are more than 60 million pieces of data that have been brought together for EID2, with new information added all the time. The database is open-access, allowing registered researchers to use it, and the data can be manipulated in lots of ways to help scientists to tackle numerous questions.

Dr McIntyre said: "EID2 is useful because it gives access to sets of information on infectious pathogens which have, until now, been difficult to acquire. For example, it describes all of the known pathogens of a host species, and all of the hosts of a pathogen species. It can generate all of the recorded pathogens in a specific country or region, or all of the pathogens of a certain host in a specific country. It gives instant access to the raw data from which this information is built. It also allows the distribution of pathogens (and hosts) to be mapped."

This disease mapping is one of the most important areas where EID2 can be a valuable tool.

Research has shown that only four percent of clinically-important diseases in humans have been geographically mapped, despite half having a strong rationale for mapping.

Because EID2 can pull together novel data sources, it can quickly and accurately map diseases, and because it isn't limited as to which pathogens and hosts it can describe, it has the potential for large-scale global mapping of animal and crop diseases in the same way as is currently being undertaken for human and some animal diseases.

This can produce country-by-country, or even county-by-county, profiles of the factors affecting disease, for example factoring in prevailing climate conditions, meaning regions can best prepare to avert or manage outbreaks of emerging infections.

Dr McIntyre added: "A further valuable data provision for the EID2 is in quantifying the interactions between pathogens and their hosts using approaches such as network analysis. This is important because, for example, we know that humans originally acquired about 60% of our pathogens from animals, but we don't know which animals. Nor do we know where those animals got their pathogens from. Once we have a clear picture of the pathogen species found in different domestic and wild animal hosts, we will be able to study the possible routes by which pathogens make it into human populations.

"Is a new pathogen of, say, mice going to reach humans because they interact with us in our houses, or will it be via the cats that eat them? This kind of information is ordinarily very difficult to acquire because it requires knowledge of which hosts are affected by diseases and vice-versa, but also how often these infection events occur, or if they have ever occurred."

The EID2 data is already being used to contribute to work on emerging and zoonotic infections at a Health Protection Research Unit (HPRU) at the University of Liverpool, which was created at the end of 2013, a national centre of excellence in multidisciplinary research to protect the nation's health.

In fact the potential of the EID2 data for analysis is incredibly wide ranging, and a host of exciting ideas are being considered by the Liverpool team. Among these are plans to use data for risk analysis, predicting where and in which species certain diseases are most likely to occur, and producing estimates of where diseases can occur based on environmental data such as climate, demographics and vegetation.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genome-Editing Position Statement
A group of leading UK research organisations has today issued an initial joint statement in support of the continued use of CRISPR-Cas9 and other genome-editing techniques in preclinical research.
Monday, September 07, 2015
Expanding the DNA Alphabet: 'Extra' DNA Base Found to be Stable in Mammals
A rare DNA base, previously thought to be a temporary modification, has been shown to be stable in mammalian DNA, suggesting that it plays a key role in cellular function.
Thursday, June 25, 2015
Global Food Security (GFS) Develops New Funding Programme
New programme of research to tackle resilience of the food system.
Tuesday, June 02, 2015
£4M to Fund Important Food Crops from BBSRC and NERC
Research projects designed with industry partners to maximize impact.
Tuesday, June 02, 2015
Controlling Leaf Blotch Disease In Wheat
Scientists have found a genetic mechanism that could stop the spread of a "devastating" disease threatening wheat crops.
Thursday, February 05, 2015
Rising Temperatures Predicted to Lower Wheat Yields
An international consortium of researchers has used big data sets to predict the effects climate change on global wheat yields.
Friday, December 26, 2014
New Test For Detecting Horse Meat
New test compares differences in chemical compositions of the fat found in meats.
Tuesday, December 02, 2014
UK And India Collaborate On Future-Proof Crops
Drought-tolerant tomatoes, improved wheat and grass pea could provide crops for the future.
Friday, November 28, 2014
Drugs Used to Treat Lung Disease Work With the Body Clock
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective.
Thursday, August 14, 2014
TGAC at the Forefront of Next Generation Sequencing Capability
The Genome Analysis Centre adds two Illumina HiSeq 2500 machines to its platform suite.
Thursday, June 26, 2014
UK Diet and Health Research Awarded £4M
Funding awarded to six projects investigating diet and health to enable the food and drink industry to meet the needs of UK consumers.
Wednesday, June 25, 2014
Better Understanding of Disease Resistance Genes in Crops
Effector-triggered defence concept describes how plants protect themselves against the apoplast.
Friday, June 06, 2014
Investment Provides Access to the World’s Most Advanced Crystallography Technology
The UK community will benefit thanks to a £5.64M investment from UK research funders.
Tuesday, June 03, 2014
Public-private Research Partnership to Support Sustainable Agricultural Systems
The partnership will support projects that will help provide solutions to key challenges affecting the sustainability of the UK crop and livestock sectors.
Friday, May 23, 2014
Protective Proteins Reduce Damage to Blood Vessels
Proteins found blood have been shown to reduce damage caused to blood vessels as we age, and in conditions such as atherosclerosis and arthritis.
Thursday, May 22, 2014
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos